miRNA-133a-UCP2 pathway regulates inflammatory bowel disease progress by influencing inflammation, oxidative stress and energy metabolism

Figure 1 Successful establishment of an inflammatory bowel disease mouse model. A: The overall colon length was significantly shortened in the dextran sulfate sodium (DSS) group; B: The average weight of the mice began to decrease significantly from Day 4 in the DSS group; C: Haematoxylin and eosin staining showed damage to the colon glands, mucosal ulceration and inflammatory cell infiltration in the DSS group; different magnifications are shown. ^aP < 0.05; ^bP < 0.01.